tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Income Statement

Compare
3 Followers

Everest Medicines Ltd. Income Statement

Last quarter (Q4 2024), Everest Medicines Ltd.'s total revenue was ¥202.58M, an increase of 246.18% from the same quarter last year. In Q4, Everest Medicines Ltd.'s net income was ¥-204.48M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 706.68M¥ 125.93M¥ 12.79M¥ 54.00K¥ 0.00
Gross Profit
¥ 528.89M¥ 91.52M¥ 8.15M¥ 31.00K¥ 0.00
Operating Expenses
¥ 1.65B¥ 1.02B¥ 264.95M¥ 1.03B¥ 687.41M
Depreciation and Amortization
¥ 110.17M¥ 76.78M¥ 42.77M¥ 31.12M¥ 4.48M
EBITDA
¥ -670.04M¥ -744.63M¥ -198.91M¥ -972.78M¥ -683.03M
Operating Income
¥ -1.12B¥ -932.74M¥ -256.80M¥ -1.03B¥ -688.46M
Other Income/Expenses
¥ 75.67M¥ 88.28M¥ 9.53M¥ 17.61M¥ -4.97B
Pretax Income
¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.66B
Net Income
¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.68B
Per Share Metrics
Basic EPS
¥ -3.24¥ -2.70¥ -0.83¥ -3.44¥ -26.46
Diluted EPS
¥ -3.24¥ -2.70¥ -0.83¥ -3.44¥ -26.46
Weighted Average Shares Outstanding
320.92M 313.06M 297.63M 293.23M 214.75M
Weighted Average Shares Outstanding (Diluted)
320.92M 313.06M 297.63M 293.27M 214.75M
Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis